HMIN [Homeinns Hotel] SC 13D/A: CUSIP No. 43742E102 SCHEDULE 13D Page 2 of
[CUSIP No. 43742E102 SCHEDULE 13D Page 2 of 7 Pages 1 NAMES OF REPORTING PERSONS OppenheimerFunds, Inc. I.R.S. NO. 13-2527171]
DQ [DAQO NEW ENERGY] 6-K: (Original Filing)
[Daqo New Energy Announces Appointment of Mr. Qiangmin Zhou as Chief Technology Officer CHONGQING, China, March 1, 2016 -- Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy", the "Company" or "we"), a leading manufacturer of high-purity polysilicon for the global solar PV industry, today announced that its board of directors has approved the appointment of Mr. Qiangmin Zhou, the] []
DQ [DAQO NEW ENERGY] 6-K: Daqo New Energy Announces Appointment of Mr. Qiangmin
[Daqo New Energy Announces Appointment of Mr. Qiangmin Zhou as Chief Technology Officer CHONGQING, China, March 1, 2016 -- Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy", the "Company" or "we"), a leading manufacturer of high-purity polysilicon for the global solar PV industry, today announced that its board of directors has approved the appointment of Mr. Qiangmin Zhou, the] []
MR [Mindray Medical International] 6-K: (Original Filing)
[Mindray Announces Completion of Going Private Transaction Under the terms of the Merger Agreement, which was approved by the Company’s shareholders at an extraordinary general meeting held on February 26, 2016, each of the Company’s ordinary shares, consisting of Class A ordinary shares and Class B ordinary shares, par value HK$0.001 per share (each, a “Share”), issued and outstanding immediately] []
